Femasys (FEMY) Competitors

Femasys (NASDAQ:FEMY) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, community ranking, earnings, profitability, institutional ownership, dividends and risk.

Which has more risk and volatility, FEMY or LNSR?

Femasys has a beta of -2.82, suggesting that its share price is 382% less volatile than the S&P 500. Comparatively, LENSAR has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500.

Which has higher earnings and valuation, FEMY or LNSR?

Femasys has higher earnings, but lower revenue than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Femasys, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Femasys	$1.07M	24.61	-$14.25M	-$0.81	-1.42
LENSAR	$42.16M	2.59	-$14.38M	-$1.46	-6.45

Is FEMY or LNSR more profitable?

LENSAR has a net margin of -34.03% compared to Femasys' net margin of -1,435.77%. LENSAR's return on equity of -49.02% beat Femasys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Femasys	-1,435.77%	-141.49%	-82.30%
LENSAR	-34.03%	-49.02%	-21.12%

Do insiders and institutionals believe in FEMY or LNSR?

65.3% of Femasys shares are owned by institutional investors. Comparatively, 40.2% of LENSAR shares are owned by institutional investors. 12.3% of Femasys shares are owned by company insiders. Comparatively, 38.5% of LENSAR shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Does the MarketBeat Community prefer FEMY or LNSR?

Femasys received 26 more outperform votes than LENSAR when rated by MarketBeat users. Likewise, 72.09% of users gave Femasys an outperform vote while only 38.46% of users gave LENSAR an outperform vote.

Company	Underperform	Outperform
Femasys	Outperform Votes 31 72.09%	Underperform Votes 12 27.91%
LENSAR	Outperform Votes 5 38.46%	Underperform Votes 8 61.54%

Do analysts rate FEMY or LNSR?

Femasys currently has a consensus target price of $10.00, indicating a potential upside of 769.57%. LENSAR has a consensus target price of $8.00, indicating a potential downside of 15.07%. Given Femasys' higher probable upside, equities research analysts plainly believe Femasys is more favorable than LENSAR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Femasys	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
LENSAR	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media refer more to FEMY or LNSR?

In the previous week, LENSAR had 1 more articles in the media than Femasys. MarketBeat recorded 1 mentions for LENSAR and 0 mentions for Femasys. LENSAR's average media sentiment score of 0.40 beat Femasys' score of 0.00 indicating that LENSAR is being referred to more favorably in the news media.

Company	Overall Sentiment
Femasys	Neutral
LENSAR	Neutral

Summary

Femasys beats LENSAR on 9 of the 17 factors compared between the two stocks.